ATS — ATS Corporation

ATS Corporation Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• Revenue: $737 million, up 6% year-over-year.
• Order Bookings: $693 million, down 15% from Q1 last year, primarily due to lower transportation orders.
• Adjusted Earnings from Operations: $79 million (10.7% of revenues), consistent with expectations and showing a slight sequential improvement from Q4.
• Gross Margin: 29.8%, stable compared to Q1 last year.
• Order Backlog: Approximately $2.1 billion at quarter-end, providing solid revenue visibility.
• Cash Flow from Operating Activities: $156 million, supported by a $194 million EV settlement payment.
• Net Debt to Adjusted EBITDA Ratio: 3.6x, with a goal to reduce to 2-3x.

2. Strategic Updates and Business Highlights:

• Leadership Transition: Andrew Hider is stepping down, with Ryan McLeod serving as Interim CEO.
• Growth Strategy: Focus on expanding capabilities in Life Sciences, Food and Beverage, and Energy sectors, with a strong emphasis on digital offerings and services.
• Acquisitions: Recent acquisitions are contributing to revenue growth, with ongoing integration efforts yielding positive results.
• Life Sciences Performance: Strong order backlog of $1.2 billion, with notable wins in auto-injectors and radiopharma.
• Energy Sector: Increased activity, particularly in nuclear refurbishment projects, with a promising outlook for small modular reactors (SMRs).
• Innovation: Launch of a new virtual reality training platform and advancements in the multiplex system for nuclear decommissioning.

3. Forward Guidance and Outlook:

• Q2 Revenue Forecast: Expected to be between $700 million and $740 million.
• Full-Year Revenue Growth: Outlook remains unchanged, supported by a healthy order backlog and strong demand in key markets.
• Margin Improvement: Anticipated throughout fiscal 2026, although not expected to be linear.

4. Bad News, Challenges, or Points of Concern:

• Order Bookings Decline: A significant drop in order bookings compared to the previous year, particularly in transportation.
• Organic Revenue Growth: Negative 1.2% due to lower transportation revenues, offset by growth in other sectors.
• Research Funding Pressure: Some customers in the lab research space are adopting a cautious approach to capital spending due to changes in U.S. government funding, though this is not expected to materially impact overall Life Sciences performance.
• Tariff Environment: Monitoring ongoing impacts of cross-border tariffs, although no significant effects have been observed to date.

5. Notable Q&A Insights:

• Demand Environment: Despite a slower start to the year, the trailing 12-month book-to-bill ratio remains strong at 1.17, indicating confidence in growth.
• Energy Sector Growth: Most growth in the energy segment is attributed to nuclear refurbishment, with a solid outlook for future projects.
• Integration Success: Positive feedback on the integration of recent acquisitions and strong uptake of ABM tools across all businesses.
• Working Capital Management: Efforts are underway to reduce working capital to below 15% of revenues by year-end, with current levels impacted by recent acquisitions and project timing.
• M&A Activity: The company remains open to strategic acquisitions, although the focus will be on deleveraging in the near term.

Overall, ATS Corporation demonstrated solid revenue growth and maintained a strong order backlog despite some challenges in order bookings and market conditions. The leadership transition and ongoing strategic initiatives position the company for continued growth and innovation.